Model Medicines COVID-19 Drug Development Program Highlighted by Catalyst Health 2.0
Health Tech Responds to COVID-19
The Health Tech Responds to COVID-19 website is a production of Catalyst @ Health 2.0 (“Catalyst”). We believe in digital health’s ability to facilitate the response to COVID-19 and are committed to providing current information and resources on the digital health ecosystem’s response. Catalyst’s global network of health information technology entrepreneurs, software developers, health care provider and payer organizations, pharmaceutical companies, philanthropic foundations, physicians, and government representatives are utilizing their resources to address the virus.
Read More
This article originally appeared on Catalyst @ Health 2.0 (“Catalyst”), prior to the rebrand of Repurpose.AI to Model Medicines, read the full article here.
Details
Date
Mar 30, 2020
Category
Press
Reading
2 Mins
Author
Patrick ONeill
Investor Relations
Related News